Projects per year
Fingerprint
Dive into the research topics where Jann N Sarkaria is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu
Lauffenburger, D. A., Michor, F. F., Sarkaria, J. N. & Agar, N. Y. R.
9/15/23 → 8/31/24
Project: Research project
-
Development of the brain penetrant ATM inhibitor WSD0628 in combination with radiation for recurrent high grade glioma
U.S. Food and Drug Administration
9/10/23 → 5/31/24
Project: Research project
-
-
Endocytic Trafficking of ADCs in GBM cancer stem-like cells
Gladson, C. L. & Sarkaria, J. N.
National Institute of Neurological Disorders and Stroke
4/1/19 → 3/31/24
Project: Research project
-
-
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization
Chen, J., Laverty, D. J., Talele, S., Bale, A., Carlson, B. L., Porath, K. A., Bakken, K. K., Burgenske, D. M., Decker, P. A., Vaubel, R. A., Eckel-Passow, J. E., Bhargava, R., Lou, Z., Hamerlik, P., Harley, B., Elmquist, W. F., Nagel, Z. D., Gupta, S. K. & Sarkaria, J. N., 2024, In: Science translational medicine. 16, 734, eadj5962.Research output: Contribution to journal › Article › peer-review
-
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma
Zhang, W., Vaubel, R. A., Oh, J. H., Mladek, A. C., Talele, S., Zhang, W., Waller, K. L., Burgenske, D. M., Sarkaria, J. N. & Elmquist, W. F., Jan 10 2024, In: Molecular cancer therapeutics. 23, 1, p. 47-55 9 p.Research output: Contribution to journal › Article › peer-review
-
From the Operating Room to the Laboratory: Role of the Neuroscience Tissue Biorepository in the Clinical, Translational, and Basic Science Research Pipeline
Quiñones-Hinojosa, A., Basil, A., Moniz-Garcia, D., Suarez-Meade, P., Ramos, A., Jentoft, M., Middlebrooks, E., Grewal, S., Abode-Iyamah, K., Bydon, M., Sarkaria, J., Dickson, D., Swanson, K., Rosenfeld, S., Schiapparelli, P., Guerrero-Cazares, H., Chaichana, K. & Meyer, F., Feb 2024, In: Mayo Clinic proceedings. 99, 2, p. 229-240 12 p.Research output: Contribution to journal › Article › peer-review
-
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas with Somatic NF2 Mutations
Brastianos, P. K., Twohy, E. L., Gerstner, E. R., Kaufmann, T. J., Iafrate, A. J., Lennerz, J., Jeyapalan, S., Piccioni, D. E., Monga, V., Fadul, C. E., Schiff, D., Taylor, J. W., Chowdhary, S. A., Bettegowda, C., Ansstas, G., De La Fuente, M., Anderson, M. D., Shonka, N., Damek, D., Carrillo, J., & 25 others , Jan 20 2023, In: Journal of Clinical Oncology. 41, 3, p. 618-628 11 p.Research output: Contribution to journal › Article › peer-review
-
A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma
Lin, W. H., Feathers, R. W., Cooper, L. M., Lewis-Tuffin, L. J., Chen, J., Sarkaria, J. N. & Anastasiadis, P. Z., 2023, In: JCI Insight. 8, 13, e157491.Research output: Contribution to journal › Article › peer-review
Open Access